U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax -- a more traditional kind of vaccine, influential government advisers said Tuesday.
Regulators authorized the nation’s first so-called protein vaccine against COVID-19 last week, but Novavax shots cannot begin until the Centers for Disease Control and Prevention recommends how to use them.
